Related Experiment Video
Updated: Jul 14, 2026

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice
Published on: February 22, 2019
The case for maternal vaccination against pertussis
Frits R Mooi1, Sabine C de Greeff
1Laboratory for Infectious Diseases and Perinatal Screening, National Institute of Public Health and the Environment, Bilthoven, Netherlands. fr.mooi@rivm.nl
Insights
Maternal pertussis vaccination can protect infants too young to be vaccinated. This strategy may decrease infant illness and death from pertussis, especially with rising disease incidence.
Area of Science:
- Immunology
- Public Health
- Pediatrics
Background:
- Pertussis (whooping cough) incidence is rising globally, particularly in unvaccinated infants.
- Infants too young for vaccination face the highest risk of pertussis complications and death.
- Existing pertussis vaccines have high coverage but are not preventing widespread outbreaks.
Purpose of the Study:
- To evaluate maternal vaccination as a strategy to protect infants against pertussis.
- To assess the safety and efficacy of maternal pertussis immunization.
Main Methods:
- Review of existing studies on maternal vaccination with whole-cell pertussis vaccines.
- Analysis of antibody transfer and infant protection data from previous research.
- Assessment of adverse effects in mothers and infants.
Main Results:
- Maternal vaccination with whole-cell pertussis vaccines showed no serious adverse effects in mothers or infants.
- Studies indicated protection of newborn infants following maternal immunization.
- Evidence suggests antibody transfer from mother to infant confers protection against pertussis.
Conclusions:
- Maternal pertussis vaccination is a potentially effective method to safeguard newborns.
- This approach can reduce infant morbidity and mortality from pertussis.
- Further research supports maternal immunization for infant protection against pertussis.
Abstract:
Despite high vaccine coverage, the incidence of pertussis is increasing in a number of countries. Particularly alarming is the increase of pertussis in infants too young to be (fully) vaccinated, because the highest morbidity and mortality is observed in this category. Maternal vaccination offers the possibility to protect infants from birth until immunity is induced by active vaccination, and has been shown to be effective and safe for tetanus over long periods of time. Maternal vaccination studies with whole-cell pertussis vaccines have not shown serious adverse effects in mother and child. In one study, protection of newborn babies was found. Additional support for the efficacy of maternal vaccination comes from studies showing that transfer of antibodies confers protection against pertussis. Maternal vaccination might be an effective way to decrease morbidity and mortality caused by pertussis in newborn babies.
More Related Videos
13:00Intranasal Immunization and Milk Collection in Studies of Maternal Immunization in New Zealand White Rabbits (Oryctolagus cuniculus)
Published on: July 31, 2021
09:09Generating a Reproducible Model of Mid-Gestational Maternal Immune Activation using Poly(I:C) to Study Susceptibility and Resilience in Offspring
Published on: August 17, 2022
Related Concept Videos
Vaccinations
Respiratory Syncytial Virus Disease
Development of the Oral Microbiota
Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.
Diphtheria
Smallpox